Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Vir and Alnylam Expand Collaboration to Advance RNAi Therapeutics for the Treatment of Coronavirus Infection, Including COVID-19
Thursday, March 05, 2020Vir Biotechnology Inc and Alnylam Pharmaceuticals Incannounced an expansion of their existing collaboration to include the development and commercialization of RNAi therapeutics targeting SARSCoV the virus that causes the disease COVID Under the agre...
Alopexx Oncology Announces Licensing Agreement with Beijing Shenogen Pharma Group for Development and Commercialization of Novel Immunocytokine
Thursday, March 05, 2020Alopexx Oncology LLC announced that it has entered into an exclusive license agreement with Beijing Shenogen Pharma Group to develop and commercialize DILeuIL in China and other parts of Asia Alopexx will receive an upfront payment various developme...
Singapore-born digital therapeutics company inks deal with Hong Kong govt to fight COVID-19
Wednesday, March 04, 2020As the novel coronavirus COVID continues to spread a Singapore born Bostonbased digital therapeutics company has inked a deal with The University of Hong Kong and Hong Kongs Department of Health to leverage its cuttingedge wearable technology and AIp...
ACADIA Pharmaceuticals and Neuren Pharmaceuticals Announce Rare Pediatric Disease Designation for Trofinetide for the Treatment of Rett Syndrome
Wednesday, March 04, 2020ACADIA Pharmaceuticals Inc and Neuren Pharmaceuticals Limited announced that the US Food and Drug Administration FDA granted Rare Pediatric Disease RPD designation to trofinetide for the treatment of Rett syndrome a serious and rare neurological diso...
Iktos and SRI International Announce Collaboration to Combine Artificial Intelligence and Novel Automated Discovery Platform
Wednesday, March 04, 2020Iktos a company specialized in artificial intelligence AI for novel drug design and SRI International SRI a research center headquartered in Menlo Park California today announced that the companies have entered into a collaboration agreement designed...
Samsung Biologics and STCube Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug
Tuesday, March 03, 2020Samsung Biologics and STCube announced a strategic development and manufacturing service agreement for STT antibody an anticancer drug candidateUnder the agreement Samsung Biologics will offer a wide range of services from cell line development proce...
CYTOO and AskBio Enter Research Agreement to Screen Gene Therapy Candidates for Rare Muscle Disorder
Tuesday, March 03, 2020CYTOO a leading drug discovery company on muscle disorders today announced that it has entered into a research collaboration aimed at selecting a gene therapy candidate for a rare muscle disorder with Asklepios BioPharmaceutical Inc AskBio a clinical...
Takeda Agrees to Divest Select OTC and Non-Core Assets in Latin America to Hypera Pharma
Monday, March 02, 2020Takeda Pharmaceutical Company Limited announced that it has entered into an agreement to divest a portfolio of select noncore products exclusively in Latin America to Hypera SA Hypera Pharma Brazils largest pharmaceutical company with a leading posit...
Harbour BioMed Announces U.S. FDA Approval of IND for Its Next Generation anti-CTLA-4 Antibody, HBM4003, to Treat Cancer
Saturday, February 29, 2020Harbour BioMed announced US Food and Drug Administration FDA approval of its Investigational New Drug IND application to begin clinical studies with HBM its next generation antiCTLA antibody for the treatment of cancer The US study builds on an init...
Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies
Friday, February 28, 2020Biogen Inc and Sangamo Therapeutics Inc a genomic medicine company today announced that they have executed a global licensing collaboration agreement to develop and commercialize ST for tauopathies including Alzheimers disease ST for synucleinopathie...
